Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.070
-0.060 (-2.82%)
At close: Mar 11, 2026, 4:00 PM EDT
2.080
+0.010 (0.48%)
After-hours: Mar 11, 2026, 7:47 PM EDT
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $269.48 million as of March 11, 2026. Its market cap has increased by 565.39% in one year.
Market Cap
269.48M
Enterprise Value
257.64M
1-Year Change
565.39%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has decreased from $301.40M to $269.48M, a decrease of -10.59%. That is a compound annual growth rate of -1.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 151.70M | 30.66% |
| Dec 31, 2025 | 116.10M | 75.11% |
| Dec 31, 2024 | 66.30M | -70.87% |
| Dec 29, 2023 | 227.60M | 73.61% |
| Dec 30, 2022 | 131.10M | -40.03% |
| Dec 31, 2021 | 218.60M | 49.22% |
| Dec 31, 2020 | 146.50M | -26.16% |
| Dec 31, 2019 | 198.40M | 232.33% |
| Dec 31, 2018 | 59.70M | -75.41% |
| Dec 29, 2017 | 242.80M | -19.44% |
| May 5, 2017 | 301.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 292.38M |
| Coherus Oncology | 289.29M |
| AC Immune | 282.98M |
| OmniAb | 282.33M |
| ALX Oncology Holdings | 281.42M |
| Abeona Therapeutics | 279.63M |
| Cybin | 276.20M |
| Enlivex | 275.36M |